{"id":"NCT00257010","sponsor":"Janssen-Ortho LLC","briefTitle":"A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches","officialTitle":"Long-Term, Open-Label Safety Study of Oral Almotriptan Malate 12.5 mg in the Treatment of Migraine in Adolescents","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2005-11-22","resultsPosted":"2013-12-06","lastUpdate":"2014-02-21"},"enrollment":447,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"Almotriptan Malate","otherNames":[]}],"arms":[{"label":"Almotriptan Malate","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the long-term safety of almotriptan malate (a migraine headache medication) in the treatment of migraine headaches in adolescents for up to one year.","primaryOutcome":{"measure":"Number of Pain Free Headaches at 2 and 24 Hours Post-Dose","timeFrame":"2 hours and 24 hours post-dose","effectByArm":[{"arm":"Almotriptan Malate","deltaMin":3218,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":49,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=290&filename=CR002827_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":420},"commonTop":["Nasopharyngitis","Sinusitis","Upper Respiratory Tract Infection","Pharyngolaryngeal Pain","Nausea"]}}